Related Experiment Videos
Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival.
J Gonzalez1, T Harris, G Childs
1Department of Pathology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Blood Cells, Molecules & Diseases
|May 18, 2001
Summary
Interleukin-2 (IL-2) promotes T cell proliferation by regulating gene expression for cell cycle and survival. Rapamycin impacts these IL-2-driven programs, affecting T cell expansion and survival.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- Effective cellular immunity relies on antigen-specific T lymphocytes.
- Interleukin-2 (IL-2) is a key cytokine driving T cell proliferation in response to antigen stimulation.
Purpose of the Study:
- To investigate the gene expression patterns induced by IL-2 in T cells.
- To understand the molecular mechanisms by which IL-2 regulates T cell proliferation and survival.
- To elucidate the effects of rapamycin on IL-2-mediated gene expression and T cell responses.
Main Methods:
- Utilized microarrays with approximately 9000 mouse cDNAs to analyze IL-2-induced gene expression.
- Compared gene expression profiles in T cells with and without IL-2 stimulation.
- Assessed the impact of rapamycin on IL-2-driven gene expression and cellular processes.
Main Results:
- IL-2 upregulates genes involved in cell cycle progression, survival, and metabolic processes necessary for proliferation.
- IL-2 downregulates genes associated with cell cycle arrest and apoptosis.
- Rapamycin inhibits IL-2-driven proliferation by suppressing key cell cycle progression genes while preserving IL-2-induced survival pathways.
Conclusions:
- IL-2 orchestrates complex gene expression programs to dynamically control T cell proliferation and survival.
- Rapamycin interferes with IL-2 signaling, impacting T cell expansion and survival mechanisms.
- Understanding these gene expression dynamics is crucial for regulating immune responses.